Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes.

Harding, Simon P; Tomlin, Keith; Reeves, Barnaby C; Langham, Julia; Walker, Jemma; Carpenter, James; Grieve, Richard; Patton, William P; Muldrew, Katherine A; Peto, Tunde; Chakravarthy, Usha

Harding, Simon P; Tomlin, Keith; Reeves, Barnaby C; Langham, Julia; Walker, Jemma; Carpenter, James; Grieve, Richard; Patton, William P; Muldrew, Katherine A; Peto, Tunde; Chakravarthy, Usha.

Affiliation

Harding SP; Royal Liverpool University Hospital, Liverpool, England.

Ophthalmology ; 116(12): e1-8, 2009 Dec.

Article in En | MEDLINE | ID: mdl-19948275

Subject(s)

Choroidal Neovascularization/drug therapy; Macular Degeneration/drug therapy; Photochemotherapy; Photosensitizing Agents/therapeutic use; Porphyrins/therapeutic use; Visual Acuity/physiology; Aged; Choroidal Neovascularization/physiopathology; Contrast Sensitivity/physiology; Female; Follow-Up Studies; Humans; Macular Degeneration/physiopathology; Male; Prospective Studies; State Medicine; Treatment Outcome; United Kingdom; Verteporfin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Porphyrins / Visual Acuity / Photosensitizing Agents / Choroidal Neovascularization / Macular Degeneration Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Ophthalmology Year: 2009 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google